Stocks Technology GDRX
NASDAQ · TechnologyGoodRx Holdings, Inc. (GDRX)
GoodRx Holdings, Inc. brought in $785.2M of revenue over the twelve months to June 30, 2026, down 1.8% from a year earlier. Net income was $16.2M, a net margin of 2.1%. Operating cash flow minus capital spending left $164.4M of free cash flow in fiscal 2025. At June 30, 2026 it held $296.1M in cash against $486.6M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
Key facts about GoodRx Holdings, Inc.
- Net worth
- GoodRx Holdings, Inc. has a market value (market cap) of $1.2B at the latest share price, and shareholders' equity of $647.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $796.9M (+0.6% year on year), with net income of $30.4M. Over the 12 months to June 30, 2026: revenue $785.2M, net income $16.2M.
- Cash flow
- In fiscal 2025 operations brought in $167.9M of cash; after $3.5M of capital spending, free cash flow was $164.4M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 5, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- GoodRx Holdings, Inc.'s next report was expected around November 3, 2026 and is not on file with the SEC yet.
What GoodRx Holdings, Inc. does
GoodRx Holdings, Inc. is registered with the SEC under industry code SIC 7374 (Services-Computer Processing & Data Preparation). Its shares trade on NASDAQ under the ticker GDRX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $796.9M | $30.4M | $0.09 | $164.4M |
| 2024 | $792.3M | $16.4M | $0.04 | $182.7M |
| 2023 | $750.3M | -$8.9M | -$0.02 | $137.2M |
| 2022 | $766.6M | -$32.8M | -$0.08 | $142.8M |
| 2021 | $745.4M | -$25.3M | -$0.06 | $174.2M |
| 2020 | $550.7M | -$293.6M | -$1.07 | $110.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where GDRX ranks in Technology
Dividends
It paid out $1.3B in cash dividends, 3,074% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2018 | n/a | $1.3B | 3,074% |
Latest SEC filings
What GoodRx Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 2, 2026
- August 26, 2026Activist stake changed SCHEDULE 13D/A
- August 5, 2026
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 1.3% to $200.4M versus the same quarter last year; diluted EPS $0.02 versus $0.04.
- August 5, 2026
- June 18, 2026
- May 6, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 4.4% to $194M versus the same quarter last year; diluted EPS $0.00 versus $0.03.
- May 6, 2026
- April 29, 2026
- April 29, 2026Additional proxy material DEFA14A
What is GDRX worth? A DCF from its reported cash flow
Insider trades
What the people running GoodRx Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $9.7M worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 8, 2026 | Bruehlman Ronald EDirector | Exercised options | 21,692 | - |
| November 2, 2026 | Bezdek TrevorDirector | Exercised options | 34,975 | - |
| October 26, 2026 | Hirsch Douglas JosephDirector | Exercised options | 20,521 | - |
| October 15, 2026 | Barnes Wendy LynnSee Remarks, Director | Exercised options | 115,149 | - |
| October 15, 2026 | Barnes Wendy LynnSee Remarks, Director | Shares withheld for tax | 50,021 | $169.1K |
| October 15, 2026 | Barnes Wendy LynnSee Remarks, Director | Exercised options | 51,177 | - |
| October 15, 2026 | Barnes Wendy LynnSee Remarks, Director | Shares withheld for tax | 22,232 | $75.1K |
| October 15, 2026 | Barnes Wendy LynnSee Remarks, Director | Exercised options | 110,963 | - |
Who owns GDRX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Francisco Partners GP IV, L.P.13D, may seek influence with 4 related filers | 32.9% | August 26, 2026 |
| Idea Men, LLC13D, may seek influence | 29.1% | March 21, 2025 |
| SEA VII Management, LLC13D, may seek influence with 4 related filers | 20.11% | September 3, 2024 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 162 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Francisco Partners Management, LP | 60,078,184 | 0 |
| Ameriprise Financial Inc | 4,746,330 | +290,570 |
| Vanguard Capital Management LLC | 4,086,521 | -174,995 |
| Silver Lake Group, L.L.C. | 3,532,276 | 0 |
| Renaissance Technologies LLC | 3,245,738 | -14,000 |
| Vanguard Portfolio Management LLC | 3,208,264 | -154,600 |
| Petrus Trust Company, LTA | 3,098,559 | 0 |
| Dimensional Fund Advisors LP | 2,560,229 | +109,088 |
| Aqr Capital Management LLC | 2,326,080 | +523,735 |
| Jane Street Group, LLC | 2,313,184 | +1,665,363 |
| Prescott Group Capital Management, L.L.C. | 2,105,502 | 0 |
| BlackRock, Inc. | 1,857,708 | -3,883 |
| Technology Crossover Management X, Ltd. | 1,653,566 | 0 |
| Geode Capital Management, LLC | 1,171,369 | +93,242 |
| Northern Trust Corp | 904,290 | +249,159 |
| Stifel Financial Corp | 868,790 | +151,391 |
| Moore Capital Management, LP | 864,044 | -665,371 |
| Goldman Sachs Group Inc | 858,326 | -199,635 |
| Two Sigma Investments, LP | 742,181 | +553,810 |
| Nano Cap New Millennium Growth Fund L P | 740,000 | 0 |
Insiders
11 insiders reported holding 3,241,350 shares in total, about $11.3M at the last price.
| Holder | Shares |
|---|---|
| Barnes Wendy LynnSee Remarks, Director | 898,490 |
| Rey-Giraud AgnesDirector | 426,286 |
| Bezdek TrevorDirector | 378,785 |
| Hirsch Douglas JosephDirector | 341,457 |
| Wagner ScottDirector | 290,097 |
| Bruehlman Ronald EDirector | 229,044 |
| Kennedy Kelly J.Director | 207,645 |
| McGinnis Christopher ASee Remarks | 198,310 |
| Nabiey RominChief Accounting Officer | 183,061 |
| Fengler JustinSee Remarks | 70,752 |
Questions about GDRX
What does GoodRx Holdings, Inc. do?
GoodRx Holdings, Inc. is a company in the Technology sector, listed on NASDAQ as GDRX. Its shares trade on NASDAQ under the ticker GDRX.
What is GoodRx Holdings, Inc.'s net worth?
GoodRx Holdings, Inc. has a market value (market cap) of $1.2B at the latest share price, and shareholders' equity of $647.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is GoodRx Holdings, Inc. profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $16.2M on revenue of $785.2M, a net margin of 2.1%.
How much revenue does GoodRx Holdings, Inc. make?
Over the twelve months to June 30, 2026 GoodRx Holdings, Inc. reported revenue of $785.2M. That is 1.8% less than a year earlier.
When did GoodRx Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from November 9, 2026.
When is GoodRx Holdings, Inc.'s next earnings report?
GoodRx Holdings, Inc.'s next report was expected around November 3, 2026 and is not on file with the SEC yet.
Similar companies
Compare GDRX with
Follow GDRX
Get an email when GoodRx Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values GoodRx Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.